8-K - Ligand Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On February 26. 2026, Ligand Pharmaceuticals Incorporated (the “Company”) issued a press release announcing its f

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated February 26, 2026. SIGNATURES Pursuant to the requirements of

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1